Delhi High Court Refuses Interim Injunction Against RTPCR Testing Kit OMISURE - 01.04.2022

Delhi High Court has refused to pass an ad interim injunction against Tata Medical and Diagnostics Limited, manufacturer of OMISURE, an RTPCR kit that was used to detect COVID-19 Omicron variant, in a suit filed by Mankind Pharma Limited seeking permanent injunction for infringement of trademark

Tags : Delhi High Court ad interim injunction Tata Medical and Diagnostics Limited OMISURE COVID-19 Omicron variant Mankind Pharma

Share :